This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Health Stocks in Motion

Updated from 3:45 p.m.

Shares of Vivus (VVUS - Get Report) were among the best-performing health-related stocks Thursday, rising 18.3% after the company announced positive results from its phase II study of Avanafil, the company's experimental impotence drug.

The drug, which was well tolerated and showed no serious adverse events, did particularly well at the 300-milligram level. "The ability to initiate intercourse in 30 minutes, which is half the time as compared to the recommended initiation time of two of the currently approved PDE5 inhibitors, while maintaining a high degree of efficacy, should help differentiate Avanafil and give men a meaningful option to treat their ED," one of the investigators in the study said. The study covered 284 patients who were treated with placebo or Avanfil at various doses for 12 weeks. Shares traded up 61 cents to $3.95.

Applied Biosystems (ABI) fell 1.5% after the company said it would cut about 250 jobs in its research and development, marketing and operations areas. Applied expects to take a pretax charge during the fourth quarter of between $20 million and $22 million, which will cover severance costs and the closing of facilities. "These adjustments are in keeping with our program to enhance Applied Biosystems' performance and should better align our resources with the needs of our customers," the company said. During fiscal 2006, the company expects to add employees in field sales and support, manufacturing quality and advanced research, it said. Shares traded down 32 cents to $20.49.

Shares of McKesson (MCK) fell modestly after the company announced a contract extension with the U.K.'s National Health Service. The contract extension, which brings the contract term to 12.75 years, up from 10 years, calls for McKesson to continue providing an electronic staff record system for managing human resources and payroll. McKesson will receive a cash payment of $143 million as part of the new extension, mostly for McKesson's investment in the project to date. Shares traded down 12 cents to $43.47.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs